FDA Form 483 (Inspectional Observations) - Top Violations 2013
Environmental Monitoring Considerations Nancy Roscioli, Ph.D. Don Hill and Associates, Inc.
A Risk-Based Approach for Investigating Environmental Monitoring Excursions
6.PARENTERAL
2-5a_MediaFill.ppt
Sterile Drug Process Inspections FDA Anita R. Michael Pharmaceutical Investigator.
Media Fill Protocol Luisa Stoppa Manufacture of sterile medicines – Advanced workshop for SFDA GMP inspectors Nanjing, the People’s Republic of China –
Progress in FDA’s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003.
Culture Media
DISCOVER DEVELOP MANUFACTURE CMO’s Challenges and Strategies in Aseptic Manufacturing Jixing Wang, Ph.D. GMP Summit 2014 September 25-26, 2014 Valencia.